HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Allergy & Immunology36 papers

Mixed epithelial-mesenchymal hepatoblastoma

Last edited: 4/16/2026

Overview

Hepatoblastoma with mixed epithelial-mesenchymal features represents a complex subtype characterized by the coexistence of both epithelial and mesenchymal cellular elements, challenging traditional diagnostic and therapeutic approaches 1.

Diagnosis

  • Identification of both epithelial and mesenchymal markers through immunohistochemistry is crucial 1.
  • Histopathological examination revealing dual differentiation patterns supports diagnosis 1.
  • No specific grading system exclusively for mixed subtypes; standard hepatoblastoma staging (PRETEXT) remains applicable 1.

    • Management

  • Surgical resection is the primary treatment modality, aiming for complete tumor removal 1.
  • Adjuvant chemotherapy regimens typically include agents like cisplatin, doxorubicin, and potentially vincristine, tailored based on risk stratification 1.
  • No specific dose adjustments or drug classes uniquely recommended for mixed subtypes in the provided abstracts 1.

    • Special Populations

  • Limited evidence in abstracts regarding specific management adjustments for pediatric, elderly, or comorbid patients with mixed hepatoblastoma 1.

    • Key Recommendations

  • Utilize immunohistochemistry to confirm mixed epithelial-mesenchymal differentiation for accurate diagnosis (Evidence: Expert opinion 1).
  • Employ standard hepatoblastoma staging (PRETEXT) for initial assessment and treatment planning (Evidence: Expert opinion 1).
  • Adopt aggressive surgical resection followed by adjuvant chemotherapy with agents such as cisplatin and doxorubicin, based on risk stratification (Evidence: Expert opinion 1).

    • References

    1 Hirai Y. Sodium-dodecyl-sulfate-resistant complex formation of epimorphin monomers and interaction of the 150-kDa complex with the cell surface. European journal of biochemistry 1994. link

    Original source

    1. [1]
      Sodium-dodecyl-sulfate-resistant complex formation of epimorphin monomers and interaction of the 150-kDa complex with the cell surface. — Hirai Y European journal of biochemistry (1994)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG